Hints and tips:
...The S&P biotech index is trading about 50 per cent below its peak in February 2021....
...A decade later, even Gene Fama, the father of the efficient markets hypothesis, grudgingly incorporated it into his models....
...Gene-editing pioneer Jennifer Doudna meanwhile called for therapies to be made available for all through increased investment in Crispr technology....
...Gene Munster, a partner at the technology investor Deepwater Asset Management, concurred. Arm “is part of the AI story....
...After a glut of early stage companies went public in 2020 and 2021, biotech markets have slumped, with the S&P XBI index of smaller biotech companies down 50 per cent since a peak in February 2021....
...A new artificial intelligence tool from Google DeepMind can help predict whether mutations in human genes are likely to be harmful....
...The S&P 500 ended last month nearly 9 per cent higher, and US Treasuries had their best month since, well, since leg warmers were in fashion....
...S&P Global forecasts that the 12-month trailing default rate for speculative-grade securities will jump from the current 2.5 per cent to 4.5 per cent by early 2024....
...Brussels has proposed loosening restrictions on some gene-edited crops....
...Two things to start: First, the EU has hit Illumina with a record fine after the world’s largest gene sequencing company completed an $8bn acquisition without the approval of Brussels, violating what regulators...
...Inclusive Capital’s results were down 6 per cent in 2022, while the S&P 500 declined by 18 per cent, people familiar said....
...Gene therapies may cure disease, but can we afford them?...
...But then he discovered the works of the Gene Fama, the University of Chicago professor and father of the efficient markets hypothesis. It all suddenly makes sense, Wheeler thought....
...Today, the company, now known as Sio Gene, is valued at $22mn. Myovant, the biggest biotech IPO in 2016, did better. Two drugs that it had purchased from Takeda won FDA approval....
...moisture-retaining) hyaluronic acid are the bricks and mortar of the skin… Superhero CollagenSuperpower Superglue for skin cell layers Collagen comes from the Greek “kolla”, for glue, and the French “gène...
...It was the worst in the US for S&P 500 companies in more than 50 years, with a fall of 20.6 per cent in the index....
...Some of its plans have merit, such as allowing gene editing of animals and plants, and permitting student loans no matter what age....
...“It’s clear that growth will slow next year, as it will for almost all big tech,” said Gene Munster, an investor at Loup Ventures....
...The striking thing is that, out of 50 stocks, all but one — Intellia Therapeutics, which develops medicine using Crispr gene-editing technology — is down since last February....
...Pfizer, in the US, is up 22.5 per cent, against almost 38 per cent for the S&P 500. It’s not just a handful of Big Pharma stocks that have lagged behind....
...The sell-off hit the entire market, with just 50 stocks in the benchmark S&P 500 index finishing the day in the green....
...CureVac, the German mRNA company, and UK gene therapy biotech Freeline Therapeutics were among those listing in the US this year....
...Leah Bhabha formaggiokitchen.com Gene’s Sausage Shop & Delicatessen, Chicago Gene’s is a cured-meat lover’s Mecca....
...Broadly defined, the sectors at risk of disintermediation account for more than half of the S&P 500....
...Last month, the S&P snubbed carmaker Tesla in its reshuffle of the S&P 500, probably over doubts about the quality of its profits....
International Edition